Subscribe to Journal
Get full journal access for 1 year
only $33.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Marian Ali, J. & Braunwald, E. Hypertrophic cardiomyopathy. Circ. Res. 121, 749–770 (2017).
Semsarian, C. & Ingles, J. in Hypertrophic Cardiomyopathy (ed Naidu, S. S). Genetics of HCM and role of genetic testing. (Springer-Verlag, London, 2015).
Thompson, A. D. et al. Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation. Genet. Med. https://doi.org/10.1038/s41436-021-01134-9 (2021).
Ababou, A. et al. Myosin binding protein C positioned to play a key role in regulation of muscle contraction: structure and interactions of domain C1. J. Mol. Biol. 384, 615–630 (2008).
Smelter, D. F., Lange, W. J. D., Cai, W., Ge, Y. & Ralphe, J. C. The HCM-linked W792R mutation in cardiac myosin-binding protein C reduces C6 FnIII domain stability. Am J Physioll Heart Circ Physiol 314, H1179–H1191 (2018).
Pricolo, M. R. et al. Protein thermodynamic destabilization in the assessment of pathogenicity of a variant of uncertain significance in cardiac myosin binding protein C. J. Cardiovasc. Transl. Res. 13, 867–877 (2020).
Helms Adam, S. et al. Spatial and functional distribution of MYBPC3 pathogenic variants and clinical outcomes in patients with hypertrophic cardiomyopathy. Circ Genom Precis. Med. 13, 396–405 (2020).
Suay-Corredera, C. et al. Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy. J. Biol. Chem. (2021). (In press).
Suay-Corredera, C. et al. Nanomechanical phenotypes in cardiac myosin-binding protein C mutants that cause hypertrophic cardiomyopathy. ACS Nano (2021). (In press).
Ito, K. et al. Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. Proc. Natl. Acad. Sci. U. S. A. 114, 7689–7694 (2017).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Suay-Corredera, C., Alegre-Cebollada, J. Correspondence on “Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation” by Thompson et al.. Genet Med (2021). https://doi.org/10.1038/s41436-021-01235-5